Like a Rolling Stone: Sting-Cgas Pathway and Cell-Free DNA as Biomarkers for Combinatorial Immunotherapy
Combining immune checkpoint inhibitors with other treatments likely to harness tumor immunity is a rising strategy in oncology. The exact modalities of such a combinatorial regimen are yet to be defined, and most attempts have relied so far on concomitant dosing, rather than sequential or phased adm...
Main Authors: | Guillaume Sicard, Frédéric Fina, Raphaelle Fanciullino, Fabrice Barlesi, Joseph Ciccolini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/12/8/758 |
Similar Items
-
Cancer immunotherapy strategies that target the cGAS-STING pathway
by: Zhuoying Tian, et al.
Published: (2022-10-01) -
Combinatorial blockade for cancer immunotherapy: targeting emerging immune checkpoint receptors
by: Dia Roy, et al.
Published: (2023-10-01) -
Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies
by: Jiawen Zhang, et al.
Published: (2024-01-01) -
Responsive manganese-based nanoplatform amplifying cGAS-STING activation for immunotherapy
by: Qingbin He, et al.
Published: (2023-04-01) -
Bidirectional regulation of the cGAS-STING pathway in the immunosuppressive tumor microenvironment and its association with immunotherapy
by: Yurui Zhang, et al.
Published: (2024-10-01)